Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Treasury Shares: 2009-2024

Historic Treasury Shares for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $3.5 billion.

  • UNITED THERAPEUTICS's Treasury Shares rose 22.64% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 22.64%. This contributed to the annual value of $3.5 billion for FY2024, which is 34.71% up from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Treasury Shares is $3.5 billion, which was up 34.71% from $2.6 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Treasury Shares registered a high of $30.2 million during FY2024, and its lowest value of $26.6 million during FY2020.
  • For the 3-year period, UNITED THERAPEUTICS's Treasury Shares averaged around $27.8 million, with its median value being $26.6 million (2023).
  • Data for UNITED THERAPEUTICS's Treasury Shares shows a peak YoY surged of 34.71% (in 2024) over the last 5 years.
  • UNITED THERAPEUTICS's Treasury Shares (Yearly) stood at $2.6 billion in 2020, then remained steady at $2.6 billion in 2021, then remained steady at $2.6 billion in 2022, then remained steady at $2.6 billion in 2023, then surged by 34.71% to $3.5 billion in 2024.